Satish Jindal
Inventor
Stats
- 7 US patents issued
- 10 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 7 US Patents Issued
- 10 US Applications Filed
- 137 Total Citation Count
- Feb 2, 2007 Most Recent Filing
- Feb 17, 1998 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| NeoGenesis, Inc. | 2
| 2003
|
| NEOGENESIS DRUG DISCOVERY, INC. | 1
| 1999
|
| PERSEPTIVE BIOSYSTEMS, INC. | 1
2 | 1999
2001 |
| BIOGEN, INC. | 2
| 2003
|
| MERCK SHARP & DOHME CORP. | 1
1 2 2 | 1998
1999 2002 2003 |
| SCHERING CORPORATION | 1
| 2005
|
Inventor Addresses
| Address | Duration |
|---|---|
| Milton, MA | Mar 27, 01 - Oct 25, 07 |
| Milton, MA, US | Oct 17, 02 - Apr 08, 04 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 2 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 1 |
| B01J: | CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS, COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS | 1 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2007/0249,682 | 2007 | Novel CD40:CD154 binding interruptor compounds and use thereof to treat immunological complications | 4 |
| 7269519 | 2007 | Method for producing and screening mass-coded combinatorial libraries for drug discovery and target validation | 0 |
| 7173046 | 2007 | CD40:CD154 binding interrupter compounds and use thereof to treat immunological complications | 6 |
| 7169563 | 2007 | Method for producing and screening mass-coded combinatorial libraries for drug discovery and target validation | 0 |
| 2006/0063,169 | 2006 | Method for producing and screening mass-coded combinatorial libraries for drug discovery and target validation | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.